V-Raf-1 Murine Leukemia Viral Oncogene Homolog 1 (RAF1) (AA 2322-2423) peptide (GST tag)

Details for Product No. ABIN935421, Supplier: Log in to see
Protein Name
  • CRAF
  • NS5
  • Raf-1
  • c-Raf
  • c-raf
  • craf
  • raf1
  • RAF1
  • 6430402F14Rik
  • AA990557
  • BB129353
  • Craf1
  • D830050J10Rik
  • v-Raf
  • raf
  • cRaf
  • Raf-1 proto-oncogene, serine/threonine kinase
  • Raf-1 proto-oncogene, serine/threonine kinase a
  • RAF proto-oncogene serine/threonine-protein kinase pseudogene
  • v-raf-leukemia viral oncogene 1
  • Raf-1 proto-oncogene, serine/threonine kinase S homeolog
  • RAF1
  • Raf1
  • raf1a
  • raf1
  • LOC100341921
  • raf1.S
Protein Region
AA 2322-2423
Hepatitis C Virus (HCV)
Escherichia coli (E. coli)
Peptide Type
Purification tag / Conjugate
This RAF1 peptide is labelled with GST tag.
ELISA, Western Blotting (WB)
Log in to see
Supplier Product No.
Log in to see
Characteristics Hepatitis C Virus NS5 Genotype-1 a (2322-2423) recombinant protein
Expression System: E.coli
Purification Proprietary chromatographic technique
Purity > 95 % pure
Background HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Alternative Names: HCV NS5 protein, Hepatitis C protein, HCV protein, Hep C protein, HCV Recombinant protein
Molecular Weight 38.34 kDa
Research Area Infection
Application Notes Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions For Research Use only
Buffer 50 mM Tris, pH 8.0, with 0 mM EDTA.
Handling Advice Avoid repeated freeze/thaw cycles.
Storage RT/-20 °C